Identifying the Genetic Associations Between Diabetes Mellitus and the Risk of Vitiligo

被引:1
作者
Zhao, Lingyun [1 ,2 ]
Hu, Meng [3 ]
Li, Li [1 ,2 ,4 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Dermatol, 37 Guo Xue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Clin Inst Inflammat & Immunol, Frontiers Sci Ctr Dis,Lab Dermatol,Frontiers Sci, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[4] Sichuan Univ, West China Hosp, Cosmet Safety & Efficacy Evaluat Ctr, Key Lab Human Evaluat & Big Data Cosmet, Chengdu, Sichuan, Peoples R China
来源
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY | 2024年 / 17卷
关键词
diabetes mellitus; type; 2; diabetes; vitiligo; Mendelian randomization; MENDELIAN RANDOMIZATION; INSTRUMENTS; BIAS;
D O I
10.2147/CCID.S480199
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Purpose: While increasing observational studies have suggested an association between diabetes mellitus (DM) and vitiligo, the causal relationship and possible mechanism remain unclear. Methods: Publicly accessible genome-wide association study (GWAS) was utilized to conduct a bidirectional two-sample Mendelian randomization (MR) analysis. GWAS data for diabetes and vitiligo were obtained from the UK Biobank Consortium (20203 cases and 388756 controls) and the current GWAS data with largest cases (GCST004785, 4680 cases and 39586 controls) for preliminary analysis, respectively. Inverse variance weighting (IVW) was used as the main analysis method. Several sensitivity analyses were utilized to test the pleiotropy or heterogeneity. To explore the possible mechanism of gene-generating effects represented by the final instrumental variables in the analysis, enrichment analysis was conducted using the DAVID and STRING database. Results: IVW method showed a significant genetic causal association between DM and vitiligo (OR = 1.20, 95% CI: 1.08-1.33, PIVW = 0.0009). Diabetes subtype analysis showed that T2D (type 2 diabetes) were associated with an increased risk of vitiligo (OR = 1.13, 95% CI: 1.00-1.27, PIVW = 0.0432). Sensitivity analysis further confirmed the robustness of the results. The enrichment analysis revealed that the genetic inducing effects of diabetes mellitus on vitiligo were primarily about pancreatic secretion and protein digestion and absorption pathway. Conclusion: Our findings provide genetic evidence that there is a notable association between T2D and an elevated risk of vitiligo in European populations. This result may explain why the co-presentation of T2D and vitiligo is often seen in observational studies, and emphasize the significance of vigilant monitoring and clinical evaluations for vitiligo in individuals diagnosed with T2D. The aberrant glucose and lipid metabolism and the primary nutrient absorption disorder of vitiligo brought on by diabetes may be the potential mechanisms behind this association.
引用
收藏
页码:2261 / 2271
页数:11
相关论文
共 46 条
  • [1] Simvastatin Prevents and Reverses Depigmentation in a Mouse Model of Vitiligo
    Agarwal, Priti
    Rashighi, Mehdi
    Essien, Kingsley I.
    Richmond, Jillian M.
    Randall, Louise
    Pazoki-Toroudi, Hamidreza
    Hunter, Christopher A.
    Harris, John E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (04) : 1080 - 1088
  • [2] Association Between Age at Diabetes Onset and Subsequent Risk of Dementia
    Amidei, Claudio Barbiellini
    Fayosse, Aurore
    Dumurgier, Julien
    Machado-Fragua, Marcos D.
    Tabak, Adam G.
    van Sloten, Thomas
    Kivimaki, Mika
    Dugravot, Aline
    Sabia, Severine
    Singh-Manoux, Archana
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (16): : 1640 - 1649
  • [3] Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus
    Barranco-Altirriba, Maria
    Alonso, Nuria
    Weber, Ralf J. M.
    Lloyd, Gavin R.
    Hernandez, Marta
    Yanes, Oscar
    Capellades, Jordi
    Jankevics, Andris
    Winder, Catherine
    Falguera, Mireia
    Franch-Nadal, Josep
    Dunn, Warwick B.
    Perera-Lluna, Alexandre
    Castelblanco, Esmeralda
    Mauricio, Didac
    [J]. CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [4] Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption
    Bowden, Jack
    Del Greco, Fabiola M.
    Minelli, Cosetta
    Zhao, Qingyuan
    Lawlor, Debbie A.
    Sheehan, Nuala A.
    Thompson, John
    Smith, George Davey
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (03) : 728 - 742
  • [5] Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
    Bowden, Jack
    Smith, George Davey
    Burgess, Stephen
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (02) : 512 - 525
  • [6] Burgess Stephen, 2019, Wellcome Open Res, V4, P186, DOI 10.12688/wellcomeopenres.15555.1
  • [7] Avoiding bias from weak instruments in Mendelian randomization studies
    Burgess, Stephen
    Thompson, Simon G.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2011, 40 (03) : 755 - 764
  • [8] Lichen planus and dyslipidaemia: a case-control study
    Dreiher, J.
    Shapiro, J.
    Cohen, A. D.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (03) : 626 - 629
  • [9] CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naive Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment
    Edwards, Jarem
    Wilmott, James S.
    Madore, Jason
    Gide, Tuba Nur
    Quek, Camelia
    Tasker, Annie
    Ferguson, Angela
    Chen, Jinbiao
    Hewavisenti, Rehana
    Hersey, Peter
    Gebhardt, Thomas
    Weninger, Wolfgang
    Britton, Warwick J.
    Saw, Robyn P. M.
    Thompson, John F.
    Menzies, Alexander M.
    Long, Georgina V.
    Scolyer, Richard A.
    Palendira, Umaimainthan
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (13) : 3036 - 3045
  • [10] Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
    Eizirik, Decio L.
    Pasquali, Lorenzo
    Cnop, Miriam
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (07) : 349 - 362